An Observational Study of Xeloda (Capecitabine) Monotherapy in Patients With Colorectal Cancer (AXEL)

ABSTRACT: This observational study will evaluate Xeloda (capecitabine) monotherapy on the effect of disease-free survival in patients with colon cancer stage III (Duke C) after surgical resection. Data will be collected for 3 years.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2100791 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR